Do you recommend starting a statin in patients above 75 years old with diabetes but no known ASCVD?

The time to benefit (TTB) for statins in primary prevention of cardiovascular events is generally about 1.5 to 3 years. This means that adults aged 50 to 75 years typically need to take statins for at least 2.5 years to achieve a meaningful reduction in major adverse cardiovascular events (MACE), su...

Taking into consideration a patient’s comorbid conditions, functional status, polypharmacy, and overall quality of life, I may counsel for starting a statin in a patient in her 70s with diabetes.

This is a good place to practice using the 4Ms and "What Matters Most." The ASCVD risk evaluation generally gives us a 10-year risk prognosis, even if we can't use it past age 75. But we can use that as a framework.

If this is a patient in their late 70s with well-controlled diabetes, with limited o...